Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021 由 Catherine Lau, George Dranitsaris

获取全文

Estimating the Cost of Illness in Colorectal Cancer Patients Who Were Hospitalized for Severe Chemotherapy-Induced Diarrhea 由 George Dranitsaris, Jean Maroun, Amil Shah

获取全文

The Rational Use of Antibiotics: The Princess Margaret Hospital Experience 由 George Dranitsaris, Kelly MacDonald, Allison McGeer

获取全文

Economic evaluation in collaborative hospital drug evaluation reports 由 Ana Ortega, María Dolores Fraga, Roberto Marín-Gil, Eduardo Lopez-Briz, Francesc Puigventós, George Dranitsaris

获取全文

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor 由 Lucio N. Gordan, David Ray, Stephen C. Ijioma, George Dranitsaris, Amanda Warner, Trevor Heritage, Matthew Fink, David Wenk, Paul Chadwick, Natasha Khrystolubova, Shachar Peles

获取全文

Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292) 由 Rachel E. Reingold, MD, Rose Parisi, MD, MBA, Guilherme Harada, MD, Andrea P. Moy, MD, George Dranitsaris, PhD, Jasmine H. Francis, MD, Julia Canestraro, OD, FAAO, Julia A. Lester, MPH, Lauren A. Kaplanis, RN, Dazhi Liu, PharmD, BCOP, Mario E. Lacouture, MD, Alexander Drilon, MD

获取全文